The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients
NCT00173095 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2005-09-15
Summary
According to Morgan et. al. (J Neurosurg 101:1026-1029, 2004): bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs, we're going to test the hypothesis in the cerebrospinal fluid of spontaneous subarachnoid hemorrhage patients.
Conditions
- Spontaneous Subarachnoid Hemorrhage
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Cheng-Mu Chen, M.D. · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Completion
- 2008-01-31
Countries
- Taiwan
More Related Trials
-
Water Drinking Test Study and Disc Hemorrhages in Normal Tension Glaucoma
NCT05075369 ·Status: UNKNOWN ·Phase: NA
-
Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31
NCT02859428 ·Status: TERMINATED
-
Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH
NCT06581757 ·Status: TERMINATED
-
Value of an Integral Color Scale on Urine Collection Bags Versus Use of a Strip in Description of Hematuria.
NCT03408288 ·Status: COMPLETED
-
Crossed Leg Sign and it's Correlation With Significant Pathology
NCT01569542 ·Status: UNKNOWN
-
Evaluation of Menses in Congenital Bleeding Disorders
NCT01261936 ·Status: UNKNOWN
-
Laboratory and Clinical Data in Antiphospholipid Patients
NCT04308564 ·Status: RECRUITING
-
Significant Pathology Associated With Crossed Leg Sign
NCT01569555 ·Status: UNKNOWN
-
Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
NCT00975455 ·Status: COMPLETED
-
Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage
NCT02405286 ·Status: COMPLETED
-
Non-Invasive Chromosomal Evaluation of 22q11.2
NCT02541058 ·Status: COMPLETED
-
Clinical Risk Scores in Prediction Outcome of Acute UGIT Bleeding in Non Cirrhotic Patients
NCT06254352 ·Status: NOT_YET_RECRUITING
-
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
NCT02250287 ·Status: COMPLETED
-
The Diagnostic Performance of Tilt Test in Athletes
NCT02316860 ·Status: COMPLETED ·Phase: NA
-
Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
NCT00154960 ·Status: UNKNOWN
-
Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome
NCT06808607 ·Status: NOT_YET_RECRUITING
-
Evaluation of Prognostic Scores in Patients With Upper Gastrointestinal Bleeding and Cancer
NCT02508883 ·Status: COMPLETED
-
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
NCT00482794 ·Status: RECRUITING
-
Prognostic Value of AIMS65 Score to Predict Outcome in Patients With Acute Upper Gastrointestinal Bleeding
NCT05773339 ·Status: UNKNOWN
-
Angelman Syndrome (AS) Biomarker Study
NCT04103333 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Standardisation of Investigations of Mild Bleeding Disorders
NCT02329899 ·Status: COMPLETED
-
Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).
NCT06603753 ·Status: NOT_YET_RECRUITING
-
Blood Coagulation Abnormalities in COVID-19 (Corona Virus Disease-19) Patients
NCT04982263 ·Status: COMPLETED
-
Lymphangioleiomyomatosis, a Study on Cathepsin K
NCT05323370 ·Status: COMPLETED
-
Using Urine Color as a Marker of Hydration Status
NCT05174793 ·Status: COMPLETED ·Phase: NA